Live Breaking News & Updates on Superior Efficacy Profile

Stay updated with breaking news from Superior efficacy profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tubulis Presents Preclinical Data for Solid Tumor Targeting ADC Candidates TUB-030 and TUB-040 Demonstrating Superior Efficacy Profile and a Wide Therapeutic Window at the AACR Annual Meeting 2024

Tubulis today presented comprehensive preclinical data on its two lead antibody-drug conjugate (ADC) candidates TUB-030 and TUB-040 at this year's Annual Meeting of the American Association for Cancer Research (AACR) in San Diego. The poster. ....

San Diego , United States , Tubuli Tubutecan , Jonas Helma Smets , Tubutecan Adcs , Product Service , Presents Preclinical Data , Solid Tumor Targeting , Superior Efficacy Profile , Wide Therapeutic Window , Annual Meeting , American Association , Cancer Research , Chief Scientific Officer , Fc Silenced Igg ,